Skip to content

Clinical study of remimazolam benzoate used for total intravenous anesthesia in laparoscopic cholecystectomy in elderly patients

Clinical study of remimazolam benzoate used for total intravenous anesthesia in laparoscopic cholecystectomy in elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117283
Enrollment
Unknown
Registered
2026-01-22
Start date
2024-07-02
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder stones, acute cholecystitis, chronic cholecystitis, gallbladder polyps

Interventions

Remimazolam Group:Induction and Maintenance of Remimazolam Benzenesulfonate

Sponsors

Baotou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age >= 60 years old (2) The surgical indications are clear, laparoscopic cholecystectomy is performed, and it also meets the indications for general anesthesia; (3) ASA grade I-III of the American Society of Anesthesiologists; (4) BMI 18.5 - 30 kg/m^2; (5) Informed consent, voluntarily participating in this trial, and signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) The subjects explicitly refused to participate in this study; (2) Those with a history of severe heart, brain, lung, liver, kidney and metabolic diseases; (3) Those with a previous history of abnormal surgical anesthesia recovery; (4) Electrocardiogram indicates: heart rate 180 mmHg and/or diastolic blood pressure > 110 mmHg, or hypotensive patients with < 90/60 mmHg; (7) Those with neurological and muscular system diseases, mental disorders and extremely poor coagulation function; (8) Those suspected of abusing anesthetic analgesics or sedatives, and those with a history of using tropisetron; (9) Those who are predicted to have or have had difficult airways; (10) Subjects considered not suitable to participate in this study by the researchers;

Design outcomes

Primary

MeasureTime frame
Bispectral index;Anesthesia induction time;Time to loss of eyelash reflex during anesthesia induction;

Secondary

MeasureTime frame
Mean Arterial Pressure;Heart rate;Blood oxygen saturation;End-tidal carbon dioxide partial pressure;Incidence of adverse reactions;Use of Vasoactive Drugs;Time to recovery from anesthesia;Sedation-Agitation Rating;Visual Simulation Score;Postoperative cognitive function;

Countries

China

Contacts

Public ContactBai Shuancheng

Baotou Central Hospital

mzkbsc@sina.com+86 472 695 5847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026